Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
The following cookies are also needed - You can choose if you want to allow them:
Natural killer cells company teams up with TCD
The Irish Times – View full story
From Galway to San Diego: ONK Therapeutics’ Aim to Usher in A New Era of Engineered NK Cell Therapies with the Goal to Ultimately Cure Cancer
JLabs – View full story
ONK inks deal for novel NK cell technology
The PharmaLetter – View full story
Maximizing synergy and mitigating resistance: novel dual-targeted natural killer cell therapies for cancer
Nature BioPharma Dealmaker – View full story
ONK and Anthony Nolan combine forces to work on blood cancer therapies
Pharmafile – View full story
ONK Therapeutics enters collaboration with blood cancer charity Anthony Nolan
Pharma Times – View full story